Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1550
+0.0050 (3.33%)
Aug 28, 2026, 3:59 PM EST
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 9.77 million as of August 28, 2026. Its market cap has decreased by -12.15% in one year.
Market Cap
9.77M
Enterprise Value
10.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.16
ChartMarket Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 9.77M, a decrease of -23.13%. That is a compound annual growth rate of -5.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 9.77M | 24.76% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hemostemix | 15.83M |
| PreveCeutical Medical | 15.29M |
| Rapid Dose Therapeutics | 15.01M |
| Britannia Life Sciences | 11.36M |
| Glow Lifetech | 8.66M |
| XORTX Therapeutics | 5.54M |
| PharmaTher Holdings | 5.46M |
| MYND Life Sciences | 5.22M |